SCHEMBL25397201

SCHEMBL25397201

COC(=O)C1(Cc2ccccc2)CC(CNC(=O)c2ccc(-c3ccccc3)cc2)=NO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ HTT P42858 1/20 0.45
▸ ROCK2 O75116 2/20 0.45
▸ PRKACA P17612 2/20 0.45
▸ GSK3A P49840 2/20 0.45
▸ GSK3B P49841 2/20 0.45
▸ PRKX P51817 2/20 0.45
▸ ROCK1 Q13464 2/20 0.45
▸ CLK4 Q9HAZ1 2/20 0.45
▸ RPS6KA5 O75582 1/20 0.45
▸ MAP4K4 O95819 1/20 0.45
▸ PRKCG P05129 1/20 0.45
▸ RPS6KB1 P23443 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ AKT1 P31749 1/20 0.45
▸ PRKCD Q05655 1/20 0.45
▸ PRKG2 Q13237 1/20 0.45
▸ DYRK1A Q13627 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25397863 0.94 CHRM1 (0.41) SMN1; SMN2NPC1RAB9AROCK2PRKACA
SCHEMBL25398162 0.91 AURKA (0.46) SMN1; SMN2ROCK2ROCK1MAP4K4PRKCG
SCHEMBL25397713 0.91 NPC1 (0.49) SMN1; SMN2NPC1RAB9AHTTGSK3B
SCHEMBL25401868 0.91 TMEM97 (0.40) SMN1; SMN2NPC1RAB9AHTTCA2
SCHEMBL25403031 0.86 LMNA (0.47) SMN1; SMN2MMP13LMNAHPGD
SCHEMBL25401149 0.86 NPC1 (0.47) SMN1; SMN2NPC1RAB9AHTTMMP13
SCHEMBL29846451 0.86 CHRNB2 (0.51) RAB9AHTTMAPK1HDAC7LMNA
SCHEMBL25396543 0.86 CHRNB2 (0.51) RAB9AHTTMAPK1HDAC7LMNA
SCHEMBL25399661 0.85 LMNA (0.37) SMN1; SMN2HTTROCK2PRKACAGSK3A
SCHEMBL25399804 0.85 HPGDS (0.41) ROCK1MAP4K4PRKCGPKN2MAP4K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 — — US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 — — US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 SMN1; SMN2 777/4885NPC1 208/4885RAB9A 715/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 SMN1; SMN2 213/4885NPC1 180/4885RAB9A 931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback